Related Articles
Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer
Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
Norcantharidin induces ferroptosis via the suppression of NRF2/HO‑1 signaling in ovarian cancer cells
Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma